$SPFX
STANDARD PREMIUM FINANCE HOLDINGS, INC.

2024 Q2 Form 10-Q Financial Statement

#000107997324000693 Filed on May 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $3.119M $2.830M
YoY Change 35.13% 36.13%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.320M $1.291M
YoY Change 37.27% 31.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.330K $7.967K
YoY Change 49.04% 27.33%
% of Gross Profit
Operating Expenses $1.568M $1.582M
YoY Change 35.93% 31.04%
Operating Profit
YoY Change
Interest Expense $1.116M $1.083M
YoY Change 23.15% 36.82%
% of Operating Profit
Other Income/Expense, Net $50.81K $47.76K
YoY Change 42.8% 73.83%
Pretax Income $435.2K $164.6K
YoY Change 75.02% 106.39%
Income Tax -$107.8K $45.79K
% Of Pretax Income -24.77% 27.82%
Net Earnings $327.5K $118.8K
YoY Change 86.01% 72.48%
Net Earnings / Revenue 10.5% 4.2%
Basic Earnings Per Share $0.11 $0.03
Diluted Earnings Per Share $0.09 $0.03
COMMON SHARES
Basic Shares Outstanding 2.905M shares 2.905M shares
Diluted Shares Outstanding 3.664M shares 3.052M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.040K $1.140K
YoY Change -99.3% -99.56%
Cash & Equivalents $1.044K $1.144K
Short-Term Investments
Other Short-Term Assets $769.4K $722.5K
YoY Change 95.41% 106.55%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $71.05M $65.95M
YoY Change 26.16% 25.32%
LONG-TERM ASSETS
Property, Plant & Equipment $132.5K $141.2K
YoY Change 34.59% 45.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $488.5K $1.070M
YoY Change -47.78% 16.92%
Total Long-Term Assets $911.9K $1.533M
YoY Change -25.17% 24.69%
TOTAL ASSETS
Total Short-Term Assets $71.05M $65.95M
Total Long-Term Assets $911.9K $1.533M
Total Assets $71.96M $67.49M
YoY Change 25.07% 25.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.809M $1.914M
YoY Change 14.3% 22.34%
Deferred Revenue
YoY Change
Short-Term Debt $51.79M $48.93M
YoY Change 26.64% 32.26%
Long-Term Debt Due $2.790M $3.416M
YoY Change 22.44% 266.28%
Total Short-Term Liabilities $56.39M $54.26M
YoY Change 25.99% 37.39%
LONG-TERM LIABILITIES
Long-Term Debt $8.608M $6.566M
YoY Change 30.81% -20.97%
Other Long-Term Liabilities $139.2K $168.2K
YoY Change 184.82% 190.45%
Total Long-Term Liabilities $8.747M $6.734M
YoY Change 31.95% -19.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.39M $54.26M
Total Long-Term Liabilities $8.747M $6.734M
Total Liabilities $65.14M $60.99M
YoY Change 26.76% 27.44%
SHAREHOLDERS EQUITY
Retained Earnings $3.399M $3.072M
YoY Change 23.49% 17.89%
Common Stock $2.905K $2.905K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.828M $6.494M
YoY Change
Total Liabilities & Shareholders Equity $71.96M $67.49M
YoY Change 25.07% 25.3%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $327.5K $118.8K
YoY Change 86.01% 72.48%
Depreciation, Depletion And Amortization $9.330K $7.967K
YoY Change 49.04% 27.33%
Cash From Operating Activities $3.468M $1.502M
YoY Change 293.24% 60.63%
INVESTING ACTIVITIES
Capital Expenditures $600.00 $26.67K
YoY Change -91.84%
Acquisitions
YoY Change
Other Investing Activities -$4.719M -$4.723M
YoY Change 20.29% 72.22%
Cash From Investing Activities -$4.720M -$4.750M
YoY Change 20.08% 73.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.252M $3.204M
YoY Change -57.36% 94.55%
NET CHANGE
Cash From Operating Activities 3.468M $1.502M
Cash From Investing Activities -4.720M -$4.750M
Cash From Financing Activities 1.252M $3.204M
Net Change In Cash -100.0 -$44.10K
YoY Change -99.91% -72.56%
FREE CASH FLOW
Cash From Operating Activities $3.468M $1.502M
Capital Expenditures $600.00 $26.67K
Free Cash Flow $3.467M $1.475M
YoY Change 296.48% 57.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2024Q1 spfx Payroll Protection Program Loan Net Of Current Portion
PayrollProtectionProgramLoanNetOfCurrentPortion
108435 usd
CY2023Q4 spfx Payroll Protection Program Loan Net Of Current Portion
PayrollProtectionProgramLoanNetOfCurrentPortion
92785 usd
CY2024Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
225113 usd
CY2024Q1 spfx Note Payable Stockholders And Related Parties Net Of Non Current Portion
NotePayableStockholdersAndRelatedPartiesNetOfNonCurrentPortion
2131000 usd
CY2023Q4 spfx Note Payable Stockholders And Related Parties Net Of Non Current Portion
NotePayableStockholdersAndRelatedPartiesNetOfNonCurrentPortion
1778000 usd
CY2024Q1 spfx Payroll Protection Program Loan Net Of Non Current Portion
PayrollProtectionProgramLoanNetOfNonCurrentPortion
7794 usd
CY2023Q4 spfx Payroll Protection Program Loan Net Of Non Current Portion
PayrollProtectionProgramLoanNetOfNonCurrentPortion
31139 usd
CY2024Q1 us-gaap Revenues
Revenues
2829953 usd
CY2023Q1 us-gaap Revenues
Revenues
2078804 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1083160 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
791647 usd
CY2024Q1 us-gaap Salaries And Wages
SalariesAndWages
529648 usd
CY2023Q1 us-gaap Salaries And Wages
SalariesAndWages
429250 usd
CY2024Q1 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
386543 usd
CY2023Q1 us-gaap Leasing Commissions Expense
LeasingCommissionsExpense
242435 usd
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
191853 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
102233 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
87820 usd
CY2024Q1 us-gaap Postage Expense
PostageExpense
30057 usd
CY2023Q1 us-gaap Postage Expense
PostageExpense
27878 usd
CY2024Q1 us-gaap Other Expenses
OtherExpenses
47759 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
27474 usd
CY2024Q1 us-gaap Other General Expense
OtherGeneralExpense
260846 usd
CY2023Q1 us-gaap Other General Expense
OtherGeneralExpense
200699 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2665359 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1999056 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
164594 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
79748 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45792 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10868 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
118802 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
68880 usd
CY2024Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
29050 usd
CY2023Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
29050 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
89752 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
39830 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2905016 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3051788 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3357414 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5952442 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7050 usd
CY2023Q1 spfx Dividends Paid On Preferred Stock
DividendsPaidOnPreferredStock
-29050 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
68880 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5999322 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6396844 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7050 usd
CY2024Q1 spfx Dividends Paid On Preferred Stock
DividendsPaidOnPreferredStock
-29050 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
118802 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6493646 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
118802 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
68880 usd
CY2024Q1 us-gaap Depreciation
Depreciation
7967 usd
CY2023Q1 us-gaap Depreciation
Depreciation
6257 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
29979 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
28285 usd
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3314 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3314 usd
CY2024Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
225113 usd
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
191853 usd
CY2024Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-394 usd
CY2023Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-28519 usd
CY2024Q1 spfx Options Issued For Services
OptionsIssuedForServices
7050 usd
CY2023Q1 spfx Options Issued For Services
OptionsIssuedForServices
7050 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
415295 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1008 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
21000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
15836 usd
CY2024Q1 spfx Increasedecrease In Drafts Payable
IncreasedecreaseInDraftsPayable
1334574 usd
CY2023Q1 spfx Increasedecrease In Drafts Payable
IncreasedecreaseInDraftsPayable
509384 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
240767 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
136446 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-29979 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-28285 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1501686 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
934859 usd
CY2024Q1 spfx Disbursements Under Premium Finance Contracts Receivable Net
DisbursementsUnderPremiumFinanceContractsReceivableNet
4714692 usd
CY2023Q1 spfx Disbursements Under Premium Finance Contracts Receivable Net
DisbursementsUnderPremiumFinanceContractsReceivableNet
2734693 usd
CY2024Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
8177 usd
CY2023Q1 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
7651 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26668 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4749537 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2742344 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
6905 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
CY2024Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2362125 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1915761 usd
CY2024Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
518698 usd
CY2023Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
42000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
242000 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
398000 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30000 usd
CY2024Q1 spfx Repayment Of Notes Payable Stockholders And Related Parties
RepaymentOfNotesPayableStockholdersAndRelatedParties
-0 usd
CY2023Q1 spfx Repayment Of Notes Payable Stockholders And Related Parties
RepaymentOfNotesPayableStockholdersAndRelatedParties
27000 usd
CY2024Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
3227 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
3062 usd
CY2024Q1 spfx Repayment Of Ppp Loan
RepaymentOfPppLoan
7695 usd
CY2023Q1 spfx Repayment Of Ppp Loan
RepaymentOfPppLoan
22883 usd
CY2024Q1 spfx Dividend Distributions Paid
DividendDistributionsPaid
29050 usd
CY2023Q1 spfx Dividend Distributions Paid
DividendDistributionsPaid
29050 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3203756 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1646766 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-44095 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-160719 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45239 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
421211 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1144 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
260492 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
1065259 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
779684 usd
CY2024Q1 spfx Operating Lease Asset Obtained In Exchange For Operating Lease Liability
OperatingLeaseAssetObtainedInExchangeForOperatingLeaseLiability
235335 usd
CY2023Q1 spfx Operating Lease Asset Obtained In Exchange For Operating Lease Liability
OperatingLeaseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q1 us-gaap Bank Overdrafts
BankOverdrafts
175448 usd
CY2023Q4 us-gaap Bank Overdrafts
BankOverdrafts
168543 usd
CY2024Q1 spfx Premium Finance Contracts Gross
PremiumFinanceContractsGross
68421630 usd
CY2023Q4 spfx Premium Finance Contracts Gross
PremiumFinanceContractsGross
63602075 usd
CY2024Q1 us-gaap Unearned Premiums
UnearnedPremiums
93843332 usd
CY2023Q4 us-gaap Unearned Premiums
UnearnedPremiums
87618261 usd
CY2024Q1 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.172 pure
CY2023Q1 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.165 pure
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zEiZ4L5mA765" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86A_zgHmxu87dLzk">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions used in valuation of deferred tax assets, allowance for credit losses, depreciable lives of property and equipment, and valuation of stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_z1tobW4PvpX3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_862_ziUE2EmaphK1">Concentration of Credit and Financial Instrument Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash and loans receivable from customers, agents, and insurance companies. The Company maintains its cash balances at two banks. Accounts at these financial institutions are insured by the Federal Deposit Insurance Corporation up to $<span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20240331_zfV3J0Hkw3Cj" title="FDIC insured amount">250,000</span>. Uninsured balances are $<span id="xdx_902_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20240331_zBibJ0bxcOM9" title="Uninsured balances">94,839</span> and $<span id="xdx_90C_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20231231_zRLEbsMtQegk" title="Uninsured balances">250,200</span> at March 31, 2024 and December 31, 2023, respectively. The Company mitigates this risk by maintaining its cash balances at high-quality financial institutions. The following table provides a reconciliation between uninsured balances and cash per the consolidated balance sheet:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--SchedulesOfReconciliationBetweenUninsuredBalancesAndCashTextBlock_zRVQuvhM4v1a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Summary of Significant Accounting Policies (Details)"> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; text-align: justify"><span id="xdx_8B4_zqST2YRMtkNc" style="display: none">Schedule of reconciliation between uninsured balances and cash per the consolidated balance sheet</span></td><td> </td> <td colspan="2" id="xdx_49C_20240331_zvvhPnLLOib7" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_496_20231231_zK67umNICRuc" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt; text-align: justify"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>March 31, 2024 <br/>(unaudited)</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt"><b>December 31, 2023</b></span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt"><b> </b></span></td></tr> <tr id="xdx_40C_eus-gaap--CashUninsuredAmount_iI_maCAOAzfOC_zEGY3DuKVc0h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 66%; text-align: justify; padding-left: 5.4pt">Uninsured balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">94,839</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">250,200</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--InsuredBalances_iI_maCAOAzfOC_z1qb2q54H8N7" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Plus: Insured balances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--PlusBalancesAtInstitutionsThatDoNotExceedFdicLimit_iI_maCAOAzfOC_zuHxgTsbKXr6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Plus: Balances at institutions that do not exceed FDIC limit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,144</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">45,239</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--PlusCashOverdraft_iI_maCAOAzfOC_zW2N6MEP5QH4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 5.4pt">Plus: Cash overdraft</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">175,448</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">168,543</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--OutstandingChecks_iI_maCAOAzfOC_zl6bzXj4yaB1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Less: Outstanding checks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(520,287</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(668,743</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: right"> </td><td style="padding-bottom: 1pt; font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--CashAndOverdraftAmount_iTI_mtCAOAzfOC_zc8CIVLeD9m5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-left: 5.4pt">Cash per Consolidated Balance Sheet</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,144</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">45,239</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company controls its credit risk in accounts receivable through credit standards, limits on exposure, by monitoring the financial condition of insurance companies, by adhering to statutory cancellation policies, and by monitoring and pursuing collections from past due accounts. We cancel policies at the earliest permissible date allowed by the statutory cancellation regulations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240331__srt--StatementGeographicalAxis__stpr--FL__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zpKMLBkGfmqk" title="Concentration risk percentage">62</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--StatementGeographicalAxis__stpr--FL__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zH65HIQIrZv1" title="Concentration risk percentage">59</span>% of the Company’s business activity is with customers located in Florida for 2024 and 2023, respectively. Approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240331__srt--StatementGeographicalAxis__stpr--GA__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zpbxqw4vt6Sf" title="Concentration risk percentage">10</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--StatementGeographicalAxis__stpr--GA__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zyesceesYsm" title="Concentration risk percentage">12</span>% of the Company’s business activity is with customers located in Georgia for 2024 and 2023, respectively. Approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240331__srt--StatementGeographicalAxis__stpr--NC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zKCMrrAUG274" title="Concentration risk percentage">9</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--StatementGeographicalAxis__stpr--NC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zUSVH2KE3Wo5" title="Concentration risk percentage">12</span>% of the Company's business activity is with customers located in North Carolina for 2024 and 2023, respectively. Approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240331__srt--StatementGeographicalAxis__stpr--SC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zvz8ua7Nxba7" title="Concentration risk percentage">11</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--StatementGeographicalAxis__stpr--SC__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zkBigyO16xp9" title="Concentration risk percentage">10</span>% of the Company's business activity is with customers located in South Carolina for 2024 and 2023, respectively. There were no other significant regional, industrial or group concentrations during the three months ended March 31, 2024 and 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
94839 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
250200 usd
CY2024Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
94839 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
250200 usd
CY2024Q1 spfx Insured Balances
InsuredBalances
250000 usd
CY2023Q4 spfx Insured Balances
InsuredBalances
250000 usd
CY2024Q1 spfx Plus Balances At Institutions That Do Not Exceed Fdic Limit
PlusBalancesAtInstitutionsThatDoNotExceedFdicLimit
1144 usd
CY2023Q4 spfx Plus Balances At Institutions That Do Not Exceed Fdic Limit
PlusBalancesAtInstitutionsThatDoNotExceedFdicLimit
45239 usd
CY2024Q1 spfx Plus Cash Overdraft
PlusCashOverdraft
175448 usd
CY2023Q4 spfx Plus Cash Overdraft
PlusCashOverdraft
168543 usd
CY2024Q1 spfx Outstanding Checks
OutstandingChecks
-520287 usd
CY2023Q4 spfx Outstanding Checks
OutstandingChecks
-668743 usd
CY2024Q1 spfx Cash And Overdraft Amount
CashAndOverdraftAmount
1144 usd
CY2023Q4 spfx Cash And Overdraft Amount
CashAndOverdraftAmount
45239 usd
CY2024Q1 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
658414 usd
CY2023Q4 us-gaap Cash Surrender Value Of Life Insurance
CashSurrenderValueOfLifeInsurance
650237 usd
CY2024Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0664 pure
CY2024Q1 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2024Q1 spfx Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
63752872 usd
CY2023Q4 spfx Insurance Premium Finance Contracts Outstanding
InsurancePremiumFinanceContractsOutstanding
57769501 usd
CY2024Q1 spfx Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
4668758 usd
CY2023Q4 spfx Insurance Premium Finance Contracts Cancelled
InsurancePremiumFinanceContractsCancelled
5832574 usd
CY2024Q1 spfx Insurance Premium Finance Contracts Gros
InsurancePremiumFinanceContractsGros
68421630 usd
CY2023Q4 spfx Insurance Premium Finance Contracts Gros
InsurancePremiumFinanceContractsGros
63602075 usd
CY2024Q1 spfx Amounts Due From Agents
AmountsDueFromAgents
872586 usd
CY2023Q4 spfx Amounts Due From Agents
AmountsDueFromAgents
804131 usd
CY2024Q1 spfx Unearned Interest
UnearnedInterest
2465503 usd
CY2023Q4 spfx Unearned Interest
UnearnedInterest
2164914 usd
CY2024Q1 spfx Insurance Premium Finance Contracts Net
InsurancePremiumFinanceContractsNet
66828713 usd
CY2023Q4 spfx Insurance Premium Finance Contracts Net
InsurancePremiumFinanceContractsNet
62241292 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1599435 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1501593 usd
CY2024Q1 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
65229278 usd
CY2023Q4 spfx Premium Finance Contracts And Related Receivable Net
PremiumFinanceContractsAndRelatedReceivableNet
60739699 usd
CY2024Q1 spfx Allowance For Premium Finance Contracts
AllowanceForPremiumFinanceContracts
1433999 usd
CY2023Q4 spfx Allowance For Premium Finance Contracts
AllowanceForPremiumFinanceContracts
1336157 usd
CY2024Q1 spfx Allowance For Amounts Due From Agents
AllowanceForAmountsDueFromAgents
165436 usd
CY2023Q4 spfx Allowance For Amounts Due From Agents
AllowanceForAmountsDueFromAgents
165436 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1599435 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1501593 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1501593 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1129498 usd
CY2024Q1 spfx Current Year Additions To Allowance
CurrentYearAdditionsToAllowance
424000 usd
CY2023 spfx Current Year Additions To Allowance
CurrentYearAdditionsToAllowance
1669000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
375586 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1639416 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
49428 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
342511 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1599435 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1501593 usd
CY2024Q1 spfx Current Additions To Allowance
CurrentAdditionsToAllowance
424000 usd
CY2023Q1 spfx Current Additions To Allowance
CurrentAdditionsToAllowance
366000 usd
CY2024Q1 spfx Contra Revenues
ContraRevenues
198887 usd
CY2023Q1 spfx Contra Revenues
ContraRevenues
174147 usd
CY2024Q1 spfx Provision For Credit Losses
ProvisionForCreditLosses
225113 usd
CY2023Q1 spfx Provision For Credit Losses
ProvisionForCreditLosses
191853 usd
CY2024Q1 spfx Premium Finance Contracts Outstanding
PremiumFinanceContractsOutstanding
63752872 usd
CY2024Q1 spfx Premium Finance Contracts Cancelled
PremiumFinanceContractsCancelled
4668758 usd
CY2024Q1 spfx Premium Finance Contracts Gross
PremiumFinanceContractsGross
68421630 usd
CY2023Q4 spfx Premium Finance Contracts Outstanding
PremiumFinanceContractsOutstanding
57769501 usd
CY2023Q4 spfx Premium Finance Contracts Cancelled
PremiumFinanceContractsCancelled
5832574 usd
CY2023Q4 spfx Premium Finance Contracts Gross
PremiumFinanceContractsGross
63602075 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
40559 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
412985 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
386317 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
271784 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
263817 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
141201 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
122500 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7967 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6257 usd
CY2024Q1 us-gaap Debtor In Possession Financing Interest Rate On Borrowings Outstanding
DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding
0.0525 pure
CY2023Q4 us-gaap Debtor In Possession Financing Interest Rate On Borrowings Outstanding
DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding
0.0525 pure
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
286196 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
80840 usd
CY2024Q1 spfx Server Lease
ServerLease
35350 usd
CY2023Q4 spfx Server Lease
ServerLease
38664 usd
CY2024Q1 spfx Total Lease Assets
TotalLeaseAssets
321546 usd
CY2023Q4 spfx Total Lease Assets
TotalLeaseAssets
119504 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
117997 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
50594 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
168199 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30246 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
286196 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
80840 usd
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
13340 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
13166 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
23992 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
27393 usd
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
37332 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M20D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y11M19D
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
34655 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
30056 usd
CY2024Q1 srt Drafts Payable
DraftsPayable
4015933 usd
CY2023Q4 srt Drafts Payable
DraftsPayable
2681359 usd
CY2024Q1 us-gaap Other Notes Payable
OtherNotesPayable
116229 usd
CY2023Q4 us-gaap Other Notes Payable
OtherNotesPayable
123924 usd
CY2024Q1 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
108435 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
92785 usd
CY2024Q1 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
7794 usd
CY2023Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
31139 usd
CY2024Q1 spfx Notes Payable Others
NotesPayableOthers
7342255 usd
CY2023Q4 spfx Notes Payable Others
NotesPayableOthers
6865557 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
2939400 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2181400 usd
CY2024Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
4402855 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
4684157 usd
CY2024Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
126000 usd
CY2023Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
128000 usd
CY2023Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
42000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
242000 usd
CY2024Q1 spfx Notes Payable Related Parties
NotesPayableRelatedParties
2486000 usd
CY2023Q4 spfx Notes Payable Related Parties
NotesPayableRelatedParties
2088000 usd
CY2024Q1 spfx Note Payable Stockholders And Related Parties Current Portion
NotePayableStockholdersAndRelatedPartiesCurrentPortion
355000 usd
CY2023Q4 spfx Note Payable Stockholders And Related Parties Current Portion
NotePayableStockholdersAndRelatedPartiesCurrentPortion
310000 usd
CY2024Q1 spfx Note Payable Stockholders And Related Parties Net Of Non Current Portion
NotePayableStockholdersAndRelatedPartiesNetOfNonCurrentPortion
2131000 usd
CY2023Q4 spfx Note Payable Stockholders And Related Parties Net Of Non Current Portion
NotePayableStockholdersAndRelatedPartiesNetOfNonCurrentPortion
1778000 usd
CY2024Q1 us-gaap Interest Expense Other
InterestExpenseOther
44000 usd
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
39000 usd
CY2024Q1 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
398000 usd
CY2023Q1 us-gaap Proceeds From Secured Notes Payable
ProceedsFromSecuredNotesPayable
30000 usd
CY2024Q1 spfx Repayments Of Other Notes Payable
RepaymentsOfOtherNotesPayable
0 usd
CY2023Q1 spfx Repayments Of Other Notes Payable
RepaymentsOfOtherNotesPayable
27000 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
10
CY2024Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
1689050 usd
CY2024Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
10
CY2024Q1 us-gaap Dividends
Dividends
29050 usd
CY2023Q1 us-gaap Dividends
Dividends
29050 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
29050 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
29050 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2905016 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2905016 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.18
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
197400 shares
CY2024Q1 spfx Sharesbased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.00
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.18
CY2023 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P6Y1M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
705224 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
0 shares
CY2024Q1 spfx Weighted Average Exercise Price Options Issued
WeightedAverageExercisePriceOptionsIssued
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
207400 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.18
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P5Y10M24D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
462878 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
197400 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.00
CY2024Q1 spfx Sharesbased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharesbasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y10M24D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
462878 usd
CY2024Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7050 usd
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7050 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.09
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y7M6D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
355600 usd
CY2024Q1 spfx Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued
0 shares
CY2024Q1 spfx Weighted Average Exercise Price Issued
WeightedAverageExercisePriceIssued
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2024Q1 spfx Share Based Compensation Arrangements By Share Based Payment Award Other Than Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1035000 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.09
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P1Y3M29D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
0 usd
CY2024Q1 spfx Warrants Exercisable
WarrantsExercisable
1035000 shares
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
7.09
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y3M29D
CY2024Q1 spfx Sharebased Compensation Arrangement By Sharebased Payment Award Otherthan Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOtherthanOptionsExercisableIntrinsicValue1
0 usd
CY2024Q1 spfx Stock Warrant Expense
StockWarrantExpense
0 usd
CY2023Q1 spfx Stock Warrant Expense
StockWarrantExpense
0 usd
CY2024Q1 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
2131000 usd
CY2023Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1778000 usd
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
spfx-20240331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
spfx-20240331_def.xml Edgar Link unprocessable
0001079973-24-000693-index-headers.html Edgar Link pending
0001079973-24-000693-index.html Edgar Link pending
0001079973-24-000693.txt Edgar Link pending
0001079973-24-000693-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
spfx-20240331.xsd Edgar Link pending
spfx_10q.htm Edgar Link pending
spfx_ex31x1.htm Edgar Link pending
spfx_ex31x2.htm Edgar Link pending
spfx_ex32x1.htm Edgar Link pending
spfx-20240331_lab.xml Edgar Link unprocessable
spfx-20240331_pre.xml Edgar Link unprocessable
spfx_10q_htm.xml Edgar Link completed